不确定潜力的克隆性血液形成:对心脏病学家的影响
Edoardo Sciatti1, Emilia D'Elia1, Mauro Gori1
1Cardiology Unit 1, ASST-Papa Giovanni XXIII.
Journal of cardiovascular medicine (Hagerstown, Md.)
|December 5, 2023
概括
骨髓干细胞中的体基因突变可能导致不确定潜力的克隆性血液形成 (CHIP),导致炎症并增加心血管风险,如心脏病发作和中风.
科学领域:
- 血液学 血液学 血液学
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓增殖性瘤 (MPNs) 在骨髓干细胞中共享体基因突变,通过炎症与心血管并发症有关.
- 现在在没有MPN的心血管疾病患者中发现了类似的突变,定义了不确定潜力的克隆性血液形成 (CHIP).
研究的目的:
- 审查克隆性血液形成,炎症和心血管疾病之间的联系.
- 为改善临床实践提供一种实用方法.
- 确定该研究领域的未满足需求.
主要方法:
- 文献综述侧重于克隆性血液形成,炎症和心血管疾病.
- 对识别MPN和心血管疾病患者遗传突变的研究进行分析.
- 综合发现,以连接CHIP,炎症和心血管结果.
主要成果:
- CHIP是一种与年龄相关的疾病,与心肌梗塞,中风和心力衰竭的风险增加有关.
- 在CHIP中,心血管并发症归因于由潜在的基因突变驱动的全身慢性炎症.
- 心血管疾病患者中这些突变的存在突出显示了血液学和心血管健康之间存在显著的重叠.
结论:
- 克隆性血液形成是通过炎症途径引起心血管疾病的新兴驱动因素.
- 需要进一步的研究来开发向疗法并改善CHIP患者的临床管理.
- 弥合血液学和心脏病学是解决该领域未满足需求的必要条件.
更多相关视频
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.3K
09:32Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture
Published on: May 8, 2018
8.6K
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
